Shopping Cart
- Remove All
- Your shopping cart is currently empty
AZD-9164, a muscarinic M3 receptor antagonist, is developed for potential use in treating chronic obstructive pulmonary disease. It is anticipated that AZD-9164 could surpass tiotropium's therapeutic index by enhancing both the extent and persistence of pulmonary function improvements, while not amplifying systemically-mediated adverse events.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | AZD-9164, a muscarinic M3 receptor antagonist, is developed for potential use in treating chronic obstructive pulmonary disease. It is anticipated that AZD-9164 could surpass tiotropium's therapeutic index by enhancing both the extent and persistence of pulmonary function improvements, while not amplifying systemically-mediated adverse events. |
Alias | J3.232.015E, CHEMBL1921904, AZD9164, 977LWC4O5D |
Molecular Weight | 465.62 |
Formula | C29H38FN2O2 |
Cas No. | 1034978-04-5 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.